WHITE PEARL
Natural health product licensed in Canada
- Licence holder
- Eastern Currents Ltd.
- NPN or DIN-HM
- 80036132
- Status
- Inactive licence
- Licence date
- 3 October 2012
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Traditionnelle
If this product were sold in France
- Conditions légales
Dioscorea oppositifolia L.: Les matières premières végétales doivent avoir subi les étapes traditionnelles d'épluchage, de lavage et de traitement thermique. L'absence d'alcaloïdes et de composés cyanogènes doit être démontrée par des bulletins d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Crassostrea gigas Source : Shell Extraction ratio : 10:1 Dry plant equivalent : 780 mg | 78 mg | Not calculated |
| Cnidium monnieri Source : Plante(s) entière Extraction ratio : 10:1 Dry plant equivalent : 380 mg | 38 mg | Not calculated |
| Bombyx batryticatus Source : En entier Extraction ratio : 10:1 Dry plant equivalent : 130 mg | 13 mg | Not calculated |
| Codonopsis pilosula Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 380 mg | 38 mg | Not calculated |
| Dioscorea oppositifolia Source : Rhizome Extraction ratio : 10:1 Dry plant equivalent : 380 mg | 38 mg | Not calculated |
| Saposhnikovia divaricata Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 260 mg | 26 mg | Not calculated |
| Eupatorium cannabinum Source : Plante Extraction ratio : 10:1 Dry plant equivalent : 380 mg | 38 mg | Not calculated |
| Astragalus membranaceus Source : Racine Extraction ratio : 10:1 Dry plant equivalent : 380 mg | 38 mg | Not calculated |
| Atractylodes macrocephala Source : Rhizome Extraction ratio : 10:1 Dry plant equivalent : 260 mg | 26 mg | Not calculated |
Non-medicinal ingredients
Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 3 Capsule | 2 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Product manufactured based on traditional Chinese medicine theory.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Source
Official Health Canada record, licence 80036132
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.